Mesoblast | MSB - Ebitda

Aktienkurs
2.06
Täglich Wechseln
0.01 0.49%
Monatlich
-12.34%
Jährlich
-7.62%
Q1 Prognose
2.02




Ebitda Veränderung Datum
Avita Medical AUD -9.69M 12.21M 2025-12
Clinuvel Pharmaceuticals AUD 27.55M 12.65M 2025-06
Cochlear AUD 306.4M 13.5M 2025-12
CSL USD 3.13B 1.17B 2025-12
Pacific Edge NZD -13.97M 332K 2024-09
Paradigm Biopharmaceuticals AUD -5.86M 3.79M 2024-12
PYC Therapeutics AUD -22.79M 1.5M 2025-12
Ramsay Health Care AUD 1.12B 10.6M 2025-12
Sonic Healthcare AUD 839.07M 51.09M 2024-12
Starpharma Holdings AUD -4.85M 1.73M 2024-12
Telix Pharmaceuticals AUD 18.42M 14.82M 2025-12